NextCure Q1 EPS $(0.61) Misses $(0.59) Estimate
Portfolio Pulse from Benzinga Newsdesk
NextCure (NASDAQ:NXTC) reported Q1 earnings with losses of $(0.61) per share, missing the consensus estimate of $(0.59) by 3.39%. This represents a 5.17% increase in losses compared to the same period last year.
May 02, 2024 | 9:09 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NextCure reported a larger than expected loss per share in Q1, missing analyst estimates and showing an increase in losses from the previous year.
Missing earnings estimates, especially with an increase in losses year-over-year, is typically seen as a negative signal to investors. This could lead to a decrease in investor confidence and potentially result in a short-term decline in NXTC's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100